Janney Montgomery Scott LLC Takes Position in AdaptHealth Corp. (NASDAQ:AHCO)

Janney Montgomery Scott LLC bought a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 78,790 shares of the company's stock, valued at approximately $854,000. Janney Montgomery Scott LLC owned about 0.06% of AdaptHealth as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the stock. Assetmark Inc. acquired a new stake in AdaptHealth during the fourth quarter worth approximately $28,000. GAMMA Investing LLC lifted its stake in shares of AdaptHealth by 175.2% during the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after purchasing an additional 4,758 shares during the period. Guggenheim Capital LLC boosted its holdings in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of AdaptHealth in the fourth quarter valued at $169,000. Finally, Humankind Investments LLC grew its position in shares of AdaptHealth by 18.3% in the fourth quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after purchasing an additional 2,776 shares during the period. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Stock Down 0.3%

Shares of AHCO traded down $0.03 during mid-day trading on Wednesday, reaching $9.37. 1,772,843 shares of the stock traded hands, compared to its average volume of 1,321,772. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.90. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of 12.88, a P/E/G ratio of 1.09 and a beta of 1.63. The company has a quick ratio of 1.07, a current ratio of 1.29 and a debt-to-equity ratio of 1.25. The stock has a fifty day simple moving average of $8.78 and a 200 day simple moving average of $9.45.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on AHCO. Royal Bank Of Canada reduced their target price on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. Truist Financial cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, May 12th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.